Friday, March 23, 2018 6:33:29 PM
DNA Dynamics, Inc. Forms Blockchain DNA LLC
ACCESSWIRE March 23, 2018
NEW YORK, NY / ACCESSWIRE / March 23, 2018 / DNA Dynamics, Inc. (OTC PINK: DNAD) announces today that is has formed a new wholly-owned subsidiary, Blockchain DNA LLC.
The company recently announced that it had sold the ATM Bitcoin Patent and would be left with a cash reserve in excess of $300,000 that would enable the new subsidiary to be self-funding in the medium term. The supplemental filing can be found on OTCMarkets.com.
DNA's CEO, Carl Grant, stated today that ''at Blockchain DNA we plan to build a small, but expert team centred around developments in the Blockchain and crypto-currency markets. With a startup fund of $300,000 tour newly launched division, will be able to start work in April on building a profitable business unit through 2018.''
DNA Dynamics, Inc. is currently vetting office space on the East Coast USA and will announce more information to shareholders once it has found a suitable location for their new operational center.
About DNA Dynamics, Inc.
Headquartered in Grandville, Michigan, and with operations in the UK, DNA Dynamics' business focuses building a sustainable and stable Crypto-currency ecosystem.
For more information please email invest@dnadynamicsinc.com.
Forward-Looking Statements
This press release may contain forward-looking statements, including information about management's view of DNA Dynamics, Inc.'s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words ''believes,'' ''expects,'' ''intends,'' ''plans,'' ''anticipates,'' or ''may,'' and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of DNA Dynamics, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on DNA Dynamics' future results. The forward-looking statements included in this press release are made only as of the date hereof. DNA Dynamics cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, DNA Dynamics undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by DNA Dynamics.
SOURCE: DNA Dynamics, Inc.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM